STK26 and breast carcinoma: In this study we provide, for the first time, evidence to show that MST4 promotes EMT via the MST4-AKT signaling pathway, together with its functions in cell proliferation, migration/invasion, cell survival, and chemoresistance, suggesting that MST4 may serve as a potential oncogene that can be exploited and targeted for breast cancer therapy.